Company intelligence / Profile preview

Sylvan Bio

Kittanning, Pennsylvania, USAsylvanbio.com ↗

Ownership: Private
Development stage: Other

Overview

Sylvan Bio is a global leader in the production of mycelial-based products using proprietary solid substrate fermentation. Their offerings include high-value fungal-derived ingredients for dietary supplements, animal health, plant/crop protection, and industrial uses. They do not have clinical results as they are not a therapeutic developer[1][2][3].

Therapeutic areas: Other
Modalities: Fungal-based productsMycelial-based products
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Sylvan Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sylvan Bio.

Explore the full profile